Percheron Therapeutics Ltd. (PERCF)
0.002
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Percheron Therapeutics Max Drawdown (5Y) : 99.63% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 99.63% |
| April 30, 2026 | 99.63% |
| March 31, 2026 | 99.63% |
| February 28, 2026 | 99.63% |
| January 31, 2026 | 99.63% |
| December 31, 2025 | 99.63% |
| November 30, 2025 | 99.63% |
| October 31, 2025 | 99.63% |
| September 30, 2025 | 99.39% |
| August 31, 2025 | 99.39% |
| July 31, 2025 | 99.39% |
| June 30, 2025 | 99.39% |
| May 31, 2025 | 99.39% |
| April 30, 2025 | 99.39% |
| March 31, 2025 | 99.39% |
| February 28, 2025 | 99.39% |
| January 31, 2025 | 99.39% |
| December 31, 2024 | 99.39% |
| November 30, 2024 | 96.64% |
| October 31, 2024 | 96.64% |
| September 30, 2024 | 96.64% |
| August 31, 2024 | 96.64% |
| July 31, 2024 | 96.64% |
| June 30, 2024 | 96.64% |
| May 31, 2024 | 96.64% |
| Date | Value |
|---|---|
| April 30, 2024 | 96.64% |
| March 31, 2024 | 96.64% |
| February 29, 2024 | 96.64% |
| January 31, 2024 | 96.64% |
| December 31, 2023 | 96.64% |
| November 30, 2023 | 90.91% |
| October 31, 2023 | 90.91% |
| September 30, 2023 | 93.64% |
| August 31, 2023 | 93.64% |
| July 31, 2023 | 93.64% |
| June 30, 2023 | 93.64% |
| May 31, 2023 | 93.64% |
| April 30, 2023 | 93.64% |
| March 31, 2023 | 93.64% |
| February 28, 2023 | 93.64% |
| January 31, 2023 | 93.64% |
| December 31, 2022 | 93.64% |
| November 30, 2022 | 93.64% |
| October 31, 2022 | 93.64% |
| September 30, 2022 | 93.64% |
| August 31, 2022 | 93.64% |
| July 31, 2022 | 93.64% |
| June 30, 2022 | 93.64% |
| May 31, 2022 | 94.60% |
| April 30, 2022 | 94.60% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Starpharma Holdings Ltd. | -- |
| Neuren Pharmaceuticals Ltd. | 65.56% |
| Mayne Pharma Group Ltd. | 89.56% |
| Acrux Ltd. | 99.51% |
| Invion Ltd. | 99.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -61.55 |
| Beta (5Y) | -0.0027 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 293.7% |
| Historical Sharpe Ratio (5Y) | -0.2097 |
| Historical Sortino (5Y) | -0.763 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 80.00% |